Join to View Full Profile
2051 Charlie Hall BlvdCharleston, SC 29414
Phone+1 843-573-2535
Fax+1 843-573-2534
Dr. Stripling is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Education & Training
Medical University of South CarolinaResidency, Pediatrics, 1996 - 2000
Texas Tech University Health Sciences Center School of MedicineClass of 1996
Certifications & Licensure
SC State Medical License 1999 - 2025
TX State Medical License 2000 - 2012
American Board of Pediatrics Pediatrics
Clinical Trials
- Allergic Disease Onset Prevention Study Start of enrollment: 2021 Sep 01
Roles: Contact
Publications & Presentations
PubMed
- 1 citationsBerdazimer gel for molluscum contagiosum in patients with atopic dermatitis.Amy S Paller, Lawrence J Green, Nanette Silverberg, Stephen Stripling, Martina Cartwright
Pediatric Dermatology. 2024-02-27 - 5 citationsBerdazimer gel for molluscum contagiosum: An integrated analysis of 3 randomized controlled trials.Jeffrey L Sugarman, Adelaide Hebert, John C Browning, Amy S Paller, Stephen Stripling
Journal of the American Academy of Dermatology. 2024-02-01 - 36 citationsRecent Developments and Advances in Atopic Dermatitis: A Focus on Epidemiology, Pathophysiology, and Treatment in the Pediatric Setting.Lawrence F Eichenfield, Stephen Stripling, Selwyn Fung, Amy Cha, Andryann O'Brien
Paediatric Drugs. 2022-07-01
Press Mentions
U.S. Food and Drug Administration Approves ZELSUVMI™ as a First-in-Class Medication for the Treatment of Molluscum ContagiosumJanuary 7th, 2024- At-Home Treatment for Molluscum Contagiosum Wins FDA ApprovalJanuary 10th, 2024
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
